Treatment of type 2 diabetes mellitus in patients with chronic kidney disease

被引：3
作者：
Gomez-Huelgas, Ricardo [1 ]
Martinez-Castelao, Alberto [2 ]
Artola, Sara [3 ]
Gorriz, Jose Luis [2 ]
Menendez, Edelmiro [4 ]
机构：
[1] Soc Espanola Med Interna SEMI, Madrid, Spain
[2] Grp Espanol Estudio Nefropatra Diabet GEENDIAB, Soc Espanola Nefrol, Valencia, Spain
[3] Red Grp Estudio Diabet Atenc Primaria redGDPS, Girona, Spain
[4] Soc Espanola Diabet, Madrid, Spain
来源：
MEDICINA CLINICA | 2014年 / 142卷 / 02期
关键词：
Type 2 diabetes mellitus; Chronic kidney disease; Cardiovascular risk factors; Elderly;
D O I：
10.1016/j.medcli.2013.10.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM) are highly prevalent chronic diseases, which represent an important public health problem and require a multidisciplinary management. T2DM is the main cause of CKD and it also causes a significant comorbidity with regard to non-diabetic nephropathy. Patients with diabetes and kidney disease represent a special risk group as they have higher morbi-mortality as well as higher risk of hypoglycemia than diabetic individuals with a normal kidney function. Treatment of T2DM in patients with CKD is controversial because of the scarcity of available evidence. The current consensus report aims to ease the appropriate selection and dosage of antidiabetic treatments as well as the establishment of safety objectives of glycemic control in patients with CKD. (C) 2013 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码：85 / 85
页数：1
相关论文
共 98 条
[1]  
Sicree R., Shaw J.E., Zimmet P.Z., The global burden of diabetes, Diabetes Atlas, pp. 15-71, (2003)
[2]  
Levey A.S., Coresh J., Chronic kidney disease, Lancet, 379, pp. 165-180, (2012)
[3]  
The global challenge of diabetes, Lancet, 371, (2008)
[4]  
Soriguer F., Goday A., Bosch-Comas A., Bordiu E., Calle-Pascual A., Carmena R., Et al., Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study, Diabetologia, 55, pp. 88-93, (2012)
[5]  
Otero A., De Francisco A., Gayoso P., Garcia F., Prevalencia de la insuficiencia renal crónica en España: Resultados del estudio EPIRC, Nefrologia, 30, pp. 78-86, (2010)
[6]  
Rodriguez-Poncelas A., Garre-Olmo J., Franch-Nadal J., Diez-Espino J., Mundet-Tuduri X., Barrot-De La Puente J., Et al., Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study, BMC Nephrol, 14, (2013)
[7]  
Martinez-Castelao A., De Alvaro F., Gorriz J.L., Epidemiology of diabetic nephropathy in Spain, Kidney Int Suppl, (2005)
[8]  
Parving H.H., Lewis J.B., Ravid M., Remuzzi G., Hunsicker L.G., Prevalence and risk factors for microalbuminuria in a referred cohort of type ii diabetic patients: A global perspective, Kidney Int, 69, pp. 2057-2063, (2006)
[9]  
Thomas M.C., Weekes A.J., Broadley O.J., Cooper M.E., Mathew T.H., The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study), Med J Aust, 185, pp. 140-144, (2006)
[10]  
KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease, Am J Kidney Dis, 49, 2 SUPPL. 2, (2007)
12345678910